Christophe Schmitt
- Hematology top 0.2%
- Hemophilia Treatment and Research 33
- Platelet Disorders and Treatments 16
- Blood Coagulation and Thrombosis Mechanisms 13
- Genetics top 1%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 14
- Myeloproliferative Neoplasms: Diagnosis and Treatment 6
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism 5
-
- Diabetes Treatment and Management 7
- Oncology top 10%
-
- HIV/AIDS drug development and treatment 6
- Co-authors
- Gallia G. LevyMidori ShimaJohannes OldenburgJohnny MahlanguRebecca Kruse‐JarresMichael U. CallaghanElina AsikaniusGuy Young
- Cited by
- HematologyGeneticsPharmacology
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
Christophe Schmitt
69 papers receiving 3.7k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Hematology 2.5k
- Genetics 842
- Pharmacology 341
- Endocrinology, Diabetes and Metabolism 354
- Oncology 377
Countries citing papers authored by Christophe Schmitt
This map shows the geographic impact of Christophe Schmitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe Schmitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe Schmitt more than expected).
Fields of papers citing papers by Christophe Schmitt
This network shows the impact of papers produced by Christophe Schmitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe Schmitt. The network helps show where Christophe Schmitt may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Christophe Schmitt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 8 | |
| 2 | 2023 | 6 | |
| 3 | 2023 | 4 | |
| 4 | 2022 | 41 | |
| 5 | 2021 | 7 | |
| 6 | 2020 | 170 | |
| 7 | 2020 | 4 | |
| 8 | 2019 | 2 | |
| 9 | 2017 | 257 | |
| 10 | Emicizumab Prophylaxis in Hemophilia A with Inhibitorsbreakdown → | 2017 | 759 |
| 11 | 2015 | 5 | |
| 12 | 2013 | 41 | |
| 13 | 2012 | 8 | |
| 14 | 2012 | 1 | |
| 15 | 2011 | 11 | |
| 16 | 2011 | 5 | |
| 17 | 2011 | 189 | |
| 18 | 2009 | 9 | |
| 19 | 2009 | 44 | |
| 20 | 1994 | 12 |
About Christophe Schmitt
Christophe Schmitt is a scholar working on Hematology, Genetics and Pharmacology, having authored 73 papers that have together received 3.8k indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (33 papers), Platelet Disorders and Treatments (16 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (14 papers), Blood Coagulation and Thrombosis Mechanisms (13 papers), Diabetes Treatment and Management (7 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), HIV/AIDS drug development and treatment (6 papers) and Pharmacogenetics and Drug Metabolism (5 papers). The work is most often cited by research in Hematology (2.5k citations), Genetics (842 citations) and Pharmacology (341 citations). Christophe Schmitt has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Gallia G. Levy, Midori Shima, Johannes Oldenburg, Johnny Mahlangu, Rebecca Kruse‐Jarres, Michael U. Callaghan, Elina Asikanius, Guy Young, Víctor Jiménez‐Yuste and Claude Négrier. Their work appears in journals such as New England Journal of Medicine, Blood and Cell Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.